65 related articles for article (PubMed ID: 23523930)
1. Natural mutations lead to enhanced proteasomal degradation of human Ncb5or, a novel flavoheme reductase.
Kálmán FS; Lizák B; Nagy SK; Mészáros T; Zámbó V; Mandl J; Csala M; Kereszturi E
Biochimie; 2013 Jul; 95(7):1403-10. PubMed ID: 23523930
[TBL] [Abstract][Full Text] [Related]
2. The reductase NCB5OR is responsive to the redox status in beta-cells and is not involved in the ER stress response.
Larade K; Jiang ZG; Dejam A; Zhu H; Bunn HF
Biochem J; 2007 Jun; 404(3):467-76. PubMed ID: 17343567
[TBL] [Abstract][Full Text] [Related]
3. The flavoheme reductase Ncb5or protects cells against endoplasmic reticulum stress-induced lipotoxicity.
Zhang Y; Larade K; Jiang ZG; Ito S; Wang W; Zhu H; Bunn HF
J Lipid Res; 2010 Jan; 51(1):53-62. PubMed ID: 19609006
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic localization of NADH cytochrome b₅ oxidoreductase (Ncb5or).
Zámbó V; Tóth M; Schlachter K; Szelényi P; Sarnyai F; Lotz G; Csala M; Kereszturi É
FEBS Lett; 2016 Mar; 590(5):661-71. PubMed ID: 26878259
[TBL] [Abstract][Full Text] [Related]
5. NCB5OR is a novel soluble NAD(P)H reductase localized in the endoplasmic reticulum.
Zhu H; Larade K; Jackson TA; Xie J; Ladoux A; Acker H; Berchner-Pfannschmidt U; Fandrey J; Cross AR; Lukat-Rodgers GS; Rodgers KR; Bunn HF
J Biol Chem; 2004 Jul; 279(29):30316-25. PubMed ID: 15131110
[TBL] [Abstract][Full Text] [Related]
6. Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.
Deng B; Parthasarathy S; Wang W; Gibney BR; Battaile KP; Lovell S; Benson DR; Zhu H
J Biol Chem; 2010 Sep; 285(39):30181-91. PubMed ID: 20630863
[TBL] [Abstract][Full Text] [Related]
7. Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.
Xie J; Zhu H; Larade K; Ladoux A; Seguritan A; Chu M; Ito S; Bronson RT; Leiter EH; Zhang CY; Rosen ED; Bunn HF
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10750-5. PubMed ID: 15247412
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H cytochrome b5 oxidoreductase deficiency in Leishmania major results in impaired linoleate synthesis followed by increased oxidative stress and cell death.
Mukherjee S; Sen Santara S; Das S; Bose M; Roy J; Adak S
J Biol Chem; 2012 Oct; 287(42):34992-35003. PubMed ID: 22923617
[TBL] [Abstract][Full Text] [Related]
9. Development of diabetes in lean Ncb5or-null mice is associated with manifestations of endoplasmic reticulum and oxidative stress in beta cells.
Wang W; Guo Y; Xu M; Huang HH; Novikova L; Larade K; Jiang ZG; Thayer TC; Frontera JR; Aires D; Ding H; Turk J; Mathews CE; Bunn HF; Stehno-Bittel L; Zhu H
Biochim Biophys Acta; 2011 Nov; 1812(11):1532-41. PubMed ID: 21839170
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal intrinsically disordered region of Ncb5or docks with the cytochrome b
Benson DR; Deng B; Kashipathy MM; Lovell S; Battaile KP; Cooper A; Gao P; Fenton AW; Zhu H
Proteins; 2024 Apr; 92(4):554-566. PubMed ID: 38041394
[TBL] [Abstract][Full Text] [Related]
11. NCB5OR Deficiency in the Cerebellum and Midbrain Leads to Dehydration and Alterations in Thirst Response, Fasted Feeding Behavior, and Voluntary Exercise in Mice.
Stroh MA; Winter MK; McCarson KE; Thyfault JP; Zhu H
Cerebellum; 2018 Apr; 17(2):152-164. PubMed ID: 28887630
[TBL] [Abstract][Full Text] [Related]
12. Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.
Stroh MA; Winter MK; Swerdlow RH; McCarson KE; Zhu H
Metab Brain Dis; 2016 Aug; 31(4):951-64. PubMed ID: 27188291
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
Roma GW; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a cellular model with human NADH-cytochrome b5 reductase deficiency via RNA interference].
Zhuang Y; Wang S; Lan F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):400-5. PubMed ID: 18683136
[TBL] [Abstract][Full Text] [Related]
16. Identification of cytochrome-b5 reductase as the enzyme responsible for NADH-dependent lucigenin chemiluminescence in human spermatozoa.
Baker MA; Krutskikh A; Curry BJ; Hetherington L; Aitken RJ
Biol Reprod; 2005 Aug; 73(2):334-42. PubMed ID: 15858218
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.
Davis CA; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2004 Nov; 431(2):233-44. PubMed ID: 15488472
[TBL] [Abstract][Full Text] [Related]
18. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.
Fermo E; Bianchi P; Vercellati C; Marcello AP; Garatti M; Marangoni O; Barcellini W; Zanella A
Blood Cells Mol Dis; 2008; 41(1):50-5. PubMed ID: 18343696
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D.
Davis CA; Barber MJ
Arch Biochem Biophys; 2004 May; 425(2):123-32. PubMed ID: 15111120
[TBL] [Abstract][Full Text] [Related]
20. Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase.
Percy MJ; Crowley LJ; Davis CA; McMullin MF; Savage G; Hughes J; McMahon C; Quinn RJ; Smith O; Barber MJ; Lappin TR
Br J Haematol; 2005 Jun; 129(6):847-53. PubMed ID: 15953014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
